Nuvo Pharmaceuticals Inc
TSX:MRV
Nuvo Pharmaceuticals Inc
TSX:MRV
Price:
1.35 CAD
Market Closed
Updated:
May 5, 2024
Nuvo Pharmaceuticals Inc
Net Income (Common)
|
Nuvo Pharmaceuticals Inc
Net Income (Common) Peer Comparison
Comparables:
BHC
WEED
CRON
C
CURA
T
TER
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
Net Income (Common)
CA$15.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Net Income (Common)
-$592m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
32%
|
CAGR 10-Years
4%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Net Income (Common)
-CA$1.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Net Income (Common)
-$74m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Net Income (Common)
-$588.1m
|
CAGR 3-Years
-124%
|
CAGR 5-Years
-347%
|
CAGR 10-Years
N/A
|
|
T
|
Terrascend Corp
CNSX:TER
|
Net Income (Common)
-$329.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Nuvo Pharmaceuticals Inc's Net Income (Common)?
Net Income (Common)
15.2m
CAD
15.2m
CAD
Based on the financial report for Sep 30, 2022, Nuvo Pharmaceuticals Inc's Net Income (Common) amounts to 15.2m CAD.
What is Nuvo Pharmaceuticals Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
34%
34%
You don't have any saved screeners yet
